Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia
Stereotaxis Says Pauls Stradiņš Clinical University Hospital In Latvia, Establishes Robotic Center For Treatment Of Cardiac Arrhythmias In Latvia And Treats Initial Patients With Genesis Robotic Magnetic Navigation System
Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026
Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026
Stereotaxis: A Real Product Story, But The Stock Already Prices In Success
University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program
Stereotaxis Secures FDA 510(k) Clearance For GenesisX Robotic Magnetic Navigation System
Citizens Maintains Market Outperform on Stereotaxis, Lowers Price Target to $3
Stereotaxis (STXS) Q2 2026 Earnings Call Transcript
Stereotaxis, Inc. Q2 2026 Earnings Call Summary
TD Cowen Maintains Buy on Stereotaxis, Lowers Price Target to $3
Stereotaxis Q2 Earnings Call Highlights
Stereotaxis, Inc. (STXS) Q2 2026 Earnings Call Transcript
Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates
Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates
Stereotaxis Q2 EPS $(0.05) Beats $(0.06) Estimate, Sales $7.670M Miss $8.350M Estimate
Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026
University of Szeged Pioneers First Robotic Cardiology Program in Hungary
Stereotaxis (STXS) Could Be 56% Undervalued After Shelf Registration Filings
Stereotaxis Files Prospectus Related To Resale Of 108.87M Shares Of Common Stock By Selling Stockholders
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.